Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Wesana Health Holdings Inc.
  6. Summary
    WESA   CA95081C1059

WESANA HEALTH HOLDINGS INC.

(WESA)
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Canadian National Stock E…
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
1.39(c) 1.38(c) 1.29(c) 1.31(c) 1.2(c) Last
1 000 9 507 2 270 27 413 16 545 Volume
-0.71% -0.72% -6.52% +1.55% -8.40% Change
More quotes
Estimated financial data (e) (USD)
Sales 2019
Net income 2019
Net Debt 2019
P/E ratio 2019
Yield 2019
Sales 2020 0,03 M - -
Net income 2020 -0,09 M - -
Net cash position 2020 1,27 M - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 18,3 M 18,3 M -
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees -
Free-Float 62,0%
More Financials
Company
Wesana Health Holdings Inc, formerly Debut Diamonds Inc. (Debut), is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injury (TBI) and related conditions. It develops evidence-based formulations and protocols for patients to overcome neurological, psychological and mental health ailments caused by trauma. 
More about the company
All news about WESANA HEALTH HOLDINGS INC.
01/25Wesana Health Appoints Meghna A. Gaeta as Chief Marketing Officer
GL
01/18Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatme..
AQ
01/18Wesana Health Announces Positive Findings from Animal Study on Novel Depression Treatme..
CI
01/12Wesana Health Holdings Inc. Announces Executive Changes
CI
01/12Wesana Health Provides Strategic and Operational Updates
GL
01/12Wesana Health Holdings Inc. Announces Resignation of Israel Mirsky, Chief Marketing and..
CI
01/11Wesana Health Granted US FDA Pre-IND Meeting for SANA-013
GL
01/11Wesana Health Holdings Inc. Grants US FDA Pre-IND Meeting for SANA-013
CI
2021MAPS and Wesana Health Resume Negotiations
AQ
2021Wesana Health Holdings Inc. Files Patent Cooperation Treaty Patent Applications Towards..
CI
2021Wesana Completes Filing of PCT Patents for Novel Drug Protocols
GL
2021Wesana Health Reports Q3 2021 Financial Results
GL
2021Wesana Health Holdings Inc. acquired Advanced Psychiatric Management LLC.
CI
2021Wesana Health Clinics Crosses 4,000 Administered Ketamine Treatments
MT
2021Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments
AQ
More news
News in other languages on WESANA HEALTH HOLDINGS INC.
01/18Wesana Health annonce les résultats positifs d'une étude animale sur un nouveau protoco..
01/12Wesana Health Holdings Inc. annonce des changements dans sa direction
01/12Wesana Health Holdings Inc. annonce la démission d'Israel Mirsky, directeur du marketin..
01/11Wesana Health Holdings Inc. Obtient de la FDA américaine une réunion pré-IND pour SANA-..
More news
Chart WESANA HEALTH HOLDINGS INC.
Duration : Period :
Wesana Health Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Daniel Carcillo Chief Executive Officer & Director
Zed Wang Chief Financial Officer & Secretary
Chad Bronstein Executive Chairman
Mark Wingertzahn Chief Scientific Officer
Mitchell Kahn Director
Sector and Competitors
1st jan.Capi. (M$)
WESANA HEALTH HOLDINGS INC.-16.08%18
MODERNA, INC.-39.94%61 847
LONZA GROUP AG-20.30%49 060
IQVIA HOLDINGS INC.-16.27%45 129
SEAGEN INC.-19.08%22 875
ICON PUBLIC LIMITED COMPANY-19.15%20 381